Jason Fung: What Happened to “Statins Save Lives”?
Jason Fung, Physician, Nephrologist, shared a post on X about a recent article by Jes S Lindholt et al., published in European Heart Journal, adding:
“What happened to ‘statins save lives’?
In this 31,000 person RCT over 7 years, CVD screening put 44.33% of people on statins (compared to 30.25% in non screening) but prevented neither deaths nor CV events (HR 0.96).
Funny how I don’t see this trial ever being discussed by cardiologists. One major difference with this trial compared to so many other statin trials is that it is not funded by a statin maker.”
Title: Outcomes of cardiovascular screening in men aged 60–64 years: the DANCAVAS II trial
Authors: Jes S Lindholt, Anne Mejldal, Lars M. Rasmussen, Jess Lambrechtsen, Flemming H. Steffensen, Lars Frost, Kenneth Egstrup, Grazina Urbonaviciene, Martin Busk, Marek Karon, Axel Cosmus Pyndt Diederichsen
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit
-
Sep 12, 2026, 17:44Manuel Monreal: Clinical Characteristics, Treatment, and Outcomes in Hispanic vs Caucasian Patients With VTE
-
Sep 12, 2026, 17:43Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms
-
Sep 12, 2026, 17:42Elad Asher: Higher IPF Is Associated with Adverse Outcomes in ICCU
-
Sep 12, 2026, 16:40Heghine Khachatryan: From Ideal Protocols to Feasible Pathways in Hemophilia Musculoskeletal Care
-
Sep 12, 2026, 16:33Consuela A. Albright: The Strategic Value of Proclamations in Health Advocacy
-
Sep 12, 2026, 16:28Abdulrahman Al Raizah: Mitapivat for Transfusion-Dependent Thalassemia – The ENERGIZE-T Phase 3 Trial
-
Sep 12, 2026, 16:14Pierre F. Saboret: IPF and Long Term Prognosis Thrombosis and Haemostasis
-
Sep 12, 2026, 15:50Dalip Kumar: ED to Mental Health Unit Transfer Completeness Following Intentional Overdose